Pretax income is the income that a company earns before paying income taxes. Endo International's pretax income for the
three
months ended in Dec. 2023 was $-2,412 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was $-2,392 Mil.
Endo International's pretax margin was -484.65%.
During the past 13 years, Endo International's highest Pretax Margin was 4.20%. The lowest was -124.55%. And the median was -37.31%.
Endo International Pre-Tax Income Historical Data
The historical data trend for Endo International's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Endo International's Pre-Tax Income
For the Drug Manufacturers - Specialty & Generic subindustry, Endo International's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Endo International's Pre-Tax Income Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Endo International's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where Endo International's Pre-Tax Income falls into.
Endo International Pre-Tax Income Calculation
This is the income that a company earns before paying income taxes.
Endo International's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as
Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2,392 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Endo International (OTCPK:ENDPQ) Pre-Tax Income Explanation
Endo International's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as
During the past 13 years, Endo International's highest Pretax Margin was 4.20%. The lowest was -124.55%. And the median was -37.31%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Endo International Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of Endo International's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
Endo International (Endo International) Business Description
Endo International PLC is a specialty pharmaceutical company with a considerable presence in pain management, urology, orthopedics, endocrinology, bariatrics, and others. It operates in four segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals, and International Pharmaceuticals. The company generates maximum revenue from the Branded Pharmaceuticals segment. Some of its products include XIAFLEX, SUPPRELIN, PERCOCET, TESTOPEL, VASOSTRICT, ADRENALIN, and APLISOL.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ENDPQ has been successfully added to your 